These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 23291686)
21. Neurophysiolgical implications in sialidosis type 1: a case report. Wang F; Lin L; Hu J; Zhang J; Wang K Int J Neurosci; 2022 Jun; 132(6):589-592. PubMed ID: 32988250 [TBL] [Abstract][Full Text] [Related]
22. Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes. Itoh K; Naganawa Y; Matsuzawa F; Aikawa S; Doi H; Sasagasako N; Yamada T; Kira J; Kobayashi T; Pshezhetsky AV; Sakuraba H J Hum Genet; 2002; 47(1):29-37. PubMed ID: 11829139 [TBL] [Abstract][Full Text] [Related]
23. Looking "Cherry Red Spot Myoclonus" in the Eyes: Clinical Phenotype, Treatment Response, and Eye Movements in Sialidosis Type 1. Riboldi GM; Martone J; Rizzo JR; Hudson TE; Rucker JC; Frucht SJ Tremor Other Hyperkinet Mov (N Y); 2021; 11():53. PubMed ID: 34992946 [TBL] [Abstract][Full Text] [Related]
24. Gene therapy corrects the neurological deficits of mice with sialidosis. Hwu WL; Chang K; Liu YH; Wang HC; Lee NC; Chien YH Gene Ther; 2024 May; 31(5-6):263-272. PubMed ID: 38321198 [TBL] [Abstract][Full Text] [Related]
25. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex. Lukong KE; Elsliger MA; Chang Y; Richard C; Thomas G; Carey W; Tylki-Szymanska A; Czartoryska B; Buchholz T; Criado GR; Palmeri S; Pshezhetsky AV Hum Mol Genet; 2000 Apr; 9(7):1075-85. PubMed ID: 10767332 [TBL] [Abstract][Full Text] [Related]
26. NEU1 mutation in a Korean infant with type 2 sialidosis presenting as isolated fetal ascites. Lee YJ; Son SK; Park JH; Song JS; Cheon CK Pediatr Neonatol; 2015 Feb; 56(1):68-9. PubMed ID: 25223955 [No Abstract] [Full Text] [Related]
27. Modeling Sialidosis with Neural Precursor Cells Derived from Patient-Derived Induced Pluripotent Stem Cells. Seol B; Kim YD; Cho YS Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922276 [TBL] [Abstract][Full Text] [Related]
28. In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization. Bonardi D; Ravasio V; Borsani G; d'Azzo A; Bresciani R; Monti E; Giacopuzzi E PLoS One; 2014; 9(8):e104229. PubMed ID: 25153125 [TBL] [Abstract][Full Text] [Related]
29. Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient. Penzel R; Uhl J; Kopitz J; Beck M; Otto HF; Cantz M FEBS Lett; 2001 Jul; 501(2-3):135-8. PubMed ID: 11470272 [TBL] [Abstract][Full Text] [Related]
30. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression. Pattison S; Pankarican M; Rupar CA; Graham FL; Igdoura SA Hum Mutat; 2004 Jan; 23(1):32-9. PubMed ID: 14695530 [TBL] [Abstract][Full Text] [Related]
31. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase. Loren DJ; Campos Y; d'Azzo A; Wyble L; Grange DK; Gilbert-Barness E; White FV; Hamvas A J Perinatol; 2005 Jul; 25(7):491-4. PubMed ID: 15908988 [TBL] [Abstract][Full Text] [Related]
32. Cardiovascular involvement in alpha-n-acetyl neuraminidase deficiency syndromes (sialidosis type I and II). Prasanna P; Sriram CS; Rodriguez SH; Kohli U Cardiol Young; 2021 May; 31(5):862-864. PubMed ID: 33507140 [TBL] [Abstract][Full Text] [Related]
33. Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis. Zou W; Wang X; Tian G BMC Ophthalmol; 2016 Mar; 16():30. PubMed ID: 27004518 [TBL] [Abstract][Full Text] [Related]
34. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex. Lukong KE; Landry K; Elsliger MA; Chang Y; Lefrancois S; Morales CR; Pshezhetsky AV J Biol Chem; 2001 May; 276(20):17286-90. PubMed ID: 11279074 [TBL] [Abstract][Full Text] [Related]
35. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders. Kwak JE; Son MY; Son YS; Son MJ; Cho YS Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812 [TBL] [Abstract][Full Text] [Related]
36. Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient. Uhl J; Penzel R; Sergi C; Kopitz J; Otto HF; Cantz M FEBS Lett; 2002 Jun; 521(1-3):19-23. PubMed ID: 12067718 [TBL] [Abstract][Full Text] [Related]
37. [Sialidosis type I. Two cases in a family]. Chinchurreta-Capote A; Beltrán-Ureña FJ; España-Contreras M Arch Soc Esp Oftalmol; 2005 Sep; 80(9):537-40. PubMed ID: 16193438 [TBL] [Abstract][Full Text] [Related]
38. Molecular and structural studies of Japanese patients with sialidosis type 1. Naganawa Y; Itoh K; Shimmoto M; Takiguchi K; Doi H; Nishizawa Y; Kobayashi T; Kamei S; Lukong KE; Pshezhetsky AV; Sakuraba H J Hum Genet; 2000; 45(4):241-9. PubMed ID: 10944856 [TBL] [Abstract][Full Text] [Related]